About this event

  • Date and time Thu 12 Jan 2023 from 6:00pm to 8:00pm
  • Location Online
  • Organised by Ophthalmology

Join us for an evening symposium delivered by national experts which will provide a comprehensive update on the role of personalised genomic medicine in paediatric ophthalmology in 2023. The meeting will specifically outline diagnosis and surgical management of three areas of paediatric ophthalmic disease including, corneal and lens disorders and retinal gene therapy. 

The purpose of this meeting is to provide attendees with an update on the role of genetic medicine and modern surgical treatment in the diagnosis and management of paediatric ophthalmic disorders. 

Benefits of attending:

  • At the end of the symposium attendees will have an enhanced knowledge and understanding of the important role of modern genomics in the management of children with inherited eye disease.
  • Learn about diagnosis and management of conditions causing lens luxation and corneal opacification in children.
  • Attendees will be provided with an update on the retinal and ocular disorders amenable to gene therapy and the techniques used to deliver treatment.

Attendees will learn through lectures and have the opportunity to participate in an interactive question and answer sessions.

 

Follow us on: 
Facebook 
Instagram
LinkedIn
Twitter 
YouTube 

Key speakers

Miss Katie Williams

Paediatric Ophthalmology and Strabismus Fellow, Moorfields Eye Hospital

Speaker's biography

Katie Williams is a paediatric ophthalmologist currently working at Moorfields Eye Hospital. She previously completed a fellowship at Great Ormond Street Hospital. Katie completed a PhD in genetic epidemiology under the supervision of Professor Chris Hammond. She currently also holds a clinical lecturer position where she continues her research into myopia and genetic eye disease.

Mr Susmito Biswas

Consultant Paediatric Ophthalmologist, Manchester Royal Eye Hospital

Speaker's biography

Mr Susmito Biswas is a Consultant Paediatric Ophthalmologist in Manchester with specialist interest in anterior segment surgery, and retinopathy of prematurity. He is the clinical lead of paediatric ophthalmology at the Manchester Royal Eye Hospital and leads this quaternary referral subspecialty service for the North of England, where he and his team receive referrals for complex anterior segment disorders. He has been part of the clinical guidelines development group for ROP, abusive head trauma and keratoconus. He is currently the Chair of the Paediatric Subcommittee of the Royal College of Ophthalmologists. He has been Clinical Head of Division for Ophthalmology at the Manchester Royal Eye Hospital in the past. He has been part of a multidisciplinary team at Manchester involved in gene therapy and vision restoration, including the Argus II implant.

As well as learning from some of the best paediatric ophthalmologists in the world during his training, he has, over the last 21 years, had the privilege of teaching and training many paediatric ophthalmology fellows, many of whom have gone on to prominent careers in paediatric ophthalmology.

Mr Robert Henderson

Mr Robert Henderson

Consultant Paediatric Ophthalmologist and Adult / Paediatric Vitreo-Retinal Surgeon, Great Ormond Street Hospital and Moorfields Eye Hospital and Honorary Associate Professor, University College London Great Ormond Street Institute of Child Health

Speaker's biography

Mr Robert Henderson is a Consultant Paediatric Ophthalmologist and Adult / Paediatric Vitreoretinal Surgeon at Great Ormond Street Hospital and Moorfields Eye Hospital. He is Honorary Associate Professor at the UCL-GOSH Institute of Child Health. He has expertise in both surgical and genetic paediatric retinal disease.  He runs the inherited retinal dystrophy clinic at Great Ormond Street and has pioneered a new dual sensory clinic for families with hearing and visual impairment. Mr Henderson leads the Voretigene ocular gene therapy programme, at Great Ormond Street and is the North Thames Speciality lead for Ophthalmic Genomics. His research programme is investigating the role of Wnt signalling pathways in retinovascular diseases. He is running the world’s first intravitreal enzyme replacement programme for the treatment of CLN2 related Battens Disease retinal dystrophy and will be starting a phase 1 gene therapy trial sponsored by RegenxBio for the same in 2023. His interests are in developing treatments for rare inherited retinal disease.

Professor Graeme Black

Professor of Genomics and Ophthalmology, University of Manchester

Agenda

View the programme

Welcome and introduction

Mr Graham Duguid, Consultant Ophthalmologist, Western Eye Hospital and President, Ophthalmology Section, Royal Society of Medicine and Professor Ian Christopher Lloyd, Consultant Ophthalmologist and Lead Clinician Ophthalmology, Sight and Sound Division, Great Ormond Street Hospital and Honoury Professor in Paediatric Ophthalmology, University of Manchester

Clinical spectrum and investigation of ectopia lentis in children

Miss Katie Williams, Paediatric Ophthalmology and Strabismus Fellow, Moorfields Eye Hospital

Managing congenital corneal opacities

Mr Susmito Biswas, Consultant Paediatric Ophthalmologist, Manchester Royal Eye Hospital

Treatments and trials: The current state of ocular gene therapy

Mr Robert Henderson, Consultant Paediatric Ophthalmologist and Adult / Paediatric Vitreo-Retinal Surgeon, Great Ormond Street Hospital and Moorfields Eye Hospital and Honorary Associate Professor, University College London Great Ormond Street Institute of Child Health

Mainstreaming genomics medicine

Professor Graeme Black, Professor of Genomics and Ophthalmology, University of Manchester

Panel discussion
Close of meeting

Location

Online

Registration for this event will close at 5:00pm on Thursday 12 January 2023. Late registrations will not be accepted.

The agenda is subject to change at any time

If the event is recorded, we are only able to share presentations that we have received permission to share. There is no guarantee that all sessions will be available after the event, this is at the presenter’s and RSM’s discretion.

All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.

This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.

Domus - reception

While you’re attending this event

Why not stay in the comfort of our hotel, Domus Medica, book dinner in the restaurant, or even hire one of our private dining rooms to socialise with your peers?

RSM members enjoy access to our enviable club facilities. For more information, please contact our team at domus@rsm.ac.uk or restaurant@rsm.ac.uk.

Find out more